CNGT Stock Overview
Develops, markets, and sells OTC, pharmaceutical, nutraceutical, cosmetic, and health and wellness products. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Cannagistics, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -99.94% |
| 5 Year Change | -100.00% |
| Change since IPO | n/a |
Recent News & Updates
Recent updates
Shareholder Returns
| CNGT | US Logistics | US Market | |
|---|---|---|---|
| 7D | 0% | 0.3% | 2.2% |
| 1Y | n/a | -1.5% | 31.7% |
Return vs Industry: Insufficient data to determine how CNGT performed against the US Logistics industry.
Return vs Market: Insufficient data to determine how CNGT performed against the US Market.
Price Volatility
| CNGT volatility | |
|---|---|
| CNGT Average Weekly Movement | n/a |
| Logistics Industry Average Movement | 6.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CNGT's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine CNGT's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | n/a | James Zimbler | www.cannagistics.io |
Cannagistics, Inc. develops, markets, and sells OTC, pharmaceutical, nutraceutical, cosmetic, and health and wellness products. Its product portfolio includes Canagel, an anhydrous hydrogel composition and delivery system; Silverpro, a compression fabric; KidzStrips, a thin film children’s toothpaste strip; and ImmuniZin, an immune booster, as well as HydroSoil, a novel fertilizer. The company also provides IcyEase, an ice pack for muscle/joint pain; Slim-D, an appetite-suppressant oral strip; Energy Lighting Strips for oral energy; Micro Voltage Trans Derm C for pain; and CBD 600, a hemp rich oral tincture.
Cannagistics, Inc. Fundamentals Summary
| CNGT fundamental statistics | |
|---|---|
| Market cap | US$429.00 |
| Earnings (TTM) | -US$17.41m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs CNGT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CNGT income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$17.41m |
| Earnings | -US$17.41m |
Last Reported Earnings
Apr 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did CNGT perform over the long term?
See historical performance and comparison